Spinal nicotinic receptor expression in spontaneously hypertensive rats

Hypertension

Volumn 28, Issue 6, 1996, Pages 1093-1099

  Khan, Imran M ^a   Youngblood, Kenna L ^a   Printz, Morton P ^a   Yaksh, Tony L ^a,b   Taylor, Palmer ^a  

^a San Diego   (United States)

^b University of California   (United States)

Author keywords

neurotransmitters; nicotinic agonists; rats, inbred SHR; receptors, nicotinic; spinal nerves

Indexed keywords

CYTISINE; EPIBATIDINE; HYDRALAZINE; NICOTINIC AGENT; NICOTINIC RECEPTOR;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BODY WEIGHT; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DISSOCIATION CONSTANT; HEART RATE; HYPERTENSION; LIGAND BINDING; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; RECEPTOR DENSITY; SPINAL CORD; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0029851792     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.6.1093     Document Type: Article

References (28)

1. Giuliano R, Brezenoff HE. Increased central cholinergic activity in rat models of hypertension. J Cardiovasc Pharmacol. 1987;10: 113-122.
2. McCaughran JA, Murph D, Schechter N, Friedman R. Participation of the central cholinergic system in blood pressure regulation in the Dahl rat model of essential hypertension. J Cardiovasc Pharmacol. 1983;5:1005-1009.
3. Buccafusco JJ. The role of central cholinergic neurons in the regulation of blood pressure and in experimental hypertension. Pharmacol Rev. 1996;48:179-211.
4. Hoffman WE, Schmid PG, Phillips MI. Central cholinergic and noradrenergic stimulation in spontaneously hypertensive rats. J Pharmacol Exp Ther. 1978;206:644-651.
5. Tseng C-J. Appalsamy M, Robertson D, Mosqueda-Garcia R. Effects of nicotine on brain stem mechanisms of cardiovascular control. J Pharmacol Exp Ther. 1993;265:1511-1518.
6. Buccafusco JJ, Magri V. The pressor response to spinal cholinergic stimulation in spontaneously hypertensive rats. Brain Res Bull. 1990; 25:69-74.
7. Vargas HM, Brezenoff HE. Suppression of hypertension during chronic reduction of brain acetylcholine in spontaneously hypertensive rats. J Hypertens. 1988;6:739-745.
8. Khan IM, Printz MP, Yaksh TL, Taylor P. Augmented responses to intrathecal nicotinic agonists in spontaneous hypertension. Hypertension. 1994;24:611-619.
9. Yamada S, Kagawa Y, Ushijima H, Takayanagi N, Tomita T, Hayashi E. Brain nicotinic cholinoreceptor binding in spontaneous hypertension. Brain Res. 1987;410:212-218.
10. Trimarchi GR, Buccafusco JJ. Changes in regional brain synaptosomal high affinity choline uptake during the development of hypertension in spontaneously hypertensive rats. Neurochem Res. 1987;12: 247-254.
11. Heike CJ, Muth EA, Jacobowitz DM. Changes in central cholinergic neurons in the spontaneously hypertensive rat. Brain Res. 1980;188: 425-436.
12. Abdeen OA, Taylor BK, Youngblood KL, Printz MP. Peripheral beta adrenergic blockade modifies airpuff startle heart rate responses. J Pharmacol Exp Ther. 1995;272:282-289.
13. Khan IM, Yaksh TL, Taylor P. Ligand selectivity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine. J Pharmacol Exp Ther. 1994;270:159-166.
14. Badio B, Daly JW. Epibatidine, a potent analgetic and nicotinic agonist. Mol Pharmacol. 1994;45:563-569.
15. 3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Mol Pharmacol. 1995;48:280-287.
16. Khan IM, Marsala M, Printz MP, Taylor P, Yaksh TL. Intrathecal nicotinic agonist-elicited release of excitatory amino acids as measured by in vivo spinal microdialysis in rats. J Pharmacol Exp Ther. 1996;278:97-106.
17. Khan IM, Taylor P, Yaksh TL. Stimulatory pathways and sites of actions of intrathecally administered nicotinic agonists. J Pharmacol Exp Ther. 1994;271:1550-1557.
18. Kline RL, McLennan GP. Chronic hydralazine treatment alters the acute pressure-natriuresis curve in young spontaneously hypertensive rats. Can J Physiol Pharmacol. 1991;69:164-169.
19. Schlueter WA, Battle DC. Renal effects of antihypertensive drugs. Drugs. 1989;37:900-925.
20. Cushman DW, Wang FL, Fung WC, Harvey CM, DeForrest JM. Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important organs. Am J Hypertens. 1989;2:294-306.
21. van Zweiten PA. Antihypertensive drugs interacting with alpha- and beta-adrenoreceptors: a review of basic pharmacology. Drugs. 1988; 35(suppl 6):6-19.
22. Ponchon P, Grichois ML, Girolami JP, Elghozi JL. Effects of bradykinin on short-term variability in blood pressure and heart rate in rats: a spectral study. J Cardiovasc Pharmacol. 1995;25:914-923.
23. Yoshioka M, Minami M, Saito H. The anti-tachycardic mechanism of a direct-acting vasodilator, budralazine, in rats. Clin Exp Hypertens A. 1991;13:1107-1114.
24. Judy WV, Watanabe AM, Murphy WR, Aprison BS, Yu P-L. Sympathetic nerve activity and blood pressure in normotensive backcross rats genetically related to the spontaneously hypertensive rat. Hypertension. 1979;1:598-604.
25. Judy WV, Farrell SK. Arterial baroreceptor reflex control of sympathetic nerve activity in spontaneously hypertensive rat. Hypertension. 1979;1:605-614.
26. Tsoporis J, Leenen FHH. Effects of arterial vasodilators on cardiac hypertrophy and sympathetic activity in rats. Hypertension. 1988;11: 376-386.
27. Yang X-C, Buccafusco JJ. Effect of chronic treatment with acetylcholine analog methylcarbamylcholine on cortical nicotinic receptors: correlation between receptor changes and behavioral function. J Pharmacol Exp Ther. 1994;271:651-659.
28. Marks MJ, Grady SR, Collins AC. Downregulation of nicotinic receptor function after chronic nicotine infusion. J Pharmacol Exp Ther. 1993;266:1268-1276.